Vishal Patel

11PUBLICATIONS
32CO-AUTHORS
Molecular targetsBiomolecular modelling and designNanomaterialsMolecular medicineRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 14, 2026
CDK4/6 Inhibitor Abemaciclib Arrests and Reverses Kidney Cyst Progression in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease.

|Dec 12, 2025
Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease.

Christopher Y Chen, Mohamad Hadla, Ibrahim Khambati

|Nov 28, 2025
The nucleobase guanine at the 3'-terminus of oligonucleotide RGLS4326 drives off-target AMPAR inhibition and CNS toxicity.

Tania Valencia, Laura Y Yen, Cindy Berman

|May 28, 2025
An RNA transmethylation pathway governs kidney nephrogenic potential.

Harini Ramalingam, Jesus Alvarez, Andrea Flaten

|Aug 14, 2022
PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression.

Ronak Lakhia, Harini Ramalingam, Chun-Mien Chang

|Sep 14, 2019
Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease.

Edmund C Lee, Tania Valencia, Charles Allerson

Pageof 2

Frequent Collaborators

3 joint publications

Ronak Lakhia

2 joint publications

Patricia Cobo-Stark

2 joint publications

Edmund C Lee

2 joint publications

Peter Harris